Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News
  • Practices
  • People
  • Careers
  • News
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni
  • 200.Cravath

Four Decades for Justice

Read More

People

Lauren M.
Rosenberg

Partner, Litigation

lrosenberg@cravath.com
  • New York+1-212-474-1159
    • E-mail
    • Twitter
    • Facebook
    • LinkedIn
  • PDF
  • Vcard
  • Overview
  • Credentials
  • Featured Work
  • News

Lauren M. Rosenberg focuses her practice on a broad range of litigation, including general commercial, antitrust and securities matters. Ms. Rosenberg has represented a wide range of clients, including Akorn, Anadarko Petroleum, Colgate‑Palmolive, Dfinity, First Solar, Juno Therapeutics, Micro Focus International, Minerals Technologies, Morgan Stanley, Mylan, Novartis, Sabre, Time Inc. and Westpac Banking Corporation.

Some of Ms. Rosenberg’s representative matters include:

Securities Litigation

  • Representing Micro Focus International (now OpenText) and certain individual defendants in putative securities class action litigation filed in New York federal court and in California state court alleging defendants made false and misleading statements and concealed material facts regarding Micro Focus’s $8.8 billion acquisition of certain of Hewlett Packard Enterprise’s software assets. 
  • Representing Anadarko Petroleum in class action securities litigation filed in Texas federal court and double derivative litigation filed in Delaware federal court alleging Anadarko made false and misleading statements concerning the company’s business and operations in the Shenandoah deepwater oil field.
  • Representing Dfinity, an international organization developing blockchain technology, in purported class action securities litigation filed in California state and federal court related to the issuance of Dfinity’s Internet Computer Project (“ICP”) master governance tokens.
  • Representing First Solar and certain of its senior executives in putative class action securities litigation filed in Arizona federal court alleging defendants made false and misleading statements regarding the company’s “Series 6” solar module and its project development business. Ms. Rosenberg obtained the dismissal of the action in January 2023, and continues to represent First Solar in related shareholder derivative litigation.
  • Won the dismissal of a shareholder derivative suit filed in New York state court against current and former directors and officers of Novartis and several Novartis subsidiaries alleging defendants breached their fiduciary duties to Novartis by failing to conduct adequate oversight of the company’s operations.
  • Represented Akorn and its executive officers in a consolidated securities class action lawsuit and a consolidated derivative action in Illinois federal court seeking damages for alleged misrepresentations related to the company’s acquisitions of Hi-Tech Pharmacal and VersaPharm.  She also represented Akorn in related shareholder derivative actions and an SEC investigation.
  • Represented First Solar in a securities class action and related opt‑out in Arizona federal court alleging that First Solar and several of its officers and executives concealed manufacturing issues with its solar modules. The class action settled on favorable terms on the eve of trial in January 2020.  
  • Represented Juno Therapeutics and certain of its executives in a securities class action suit in Washington federal court alleging that defendants failed to disclose side effects associated with an immunotherapy drug, resulting in a stock price drop when the clinical trial was halted. 
  • Represented Westpac Banking Corporation and its current chief executive officer in a putative class action securities litigation filed in Oregon federal court alleging that Westpac failed timely to disclose that it had failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre (“AUSTRAC”), contrary to Australian law.

Antitrust Litigation

  • Representing Morgan Stanley in individual and class action lawsuits in New York federal court alleging collusion among banks to restrain competition by preventing the development of anonymous exchange trading of various complex financial products, including credit default swaps, interest rate swaps and stock loans.
  • Represented Westpac Banking Corporation in a putative class action asserting, inter alia, antitrust, RICO and Commodity Exchange Act claims premised upon alleged manipulation of the Australian Bank Bill Swap Reference Rate (“BBSW”).
  • Represented Mylan Laboratories in consolidated antitrust litigation filed in Pennsylvania federal court regarding alleged reverse-payment settlement agreements concerning the narcolepsy drug modafinil.
  • Represented Sabre, a leading travel technology company, in its successful appeal to the Second Circuit of an adverse jury verdict in an antitrust lawsuit brought by US Airways concerning Sabre’s contract terms.
  • Represented Thai Airways in class action antitrust lawsuits filed in California and New York federal courts and in the Second Circuit alleging a price‑fixing conspiracy of passenger airfares among airlines.

  • Represented Time Inc. in an antitrust action brought by a wholesaler against magazine publishers and distributors alleging a group boycott and seeking over $1 billion in damages. The Southern District of New York granted summary judgment to defendants, and the decision was affirmed on appeal in the Second Circuit.

Other Commercial Litigation

  • Won the dismissal with prejudice of litigation filed against Morgan Stanley by Moby S.p.A., an Italian shipping company, in New York state court alleging tortious interference related to Moby’s restructuring proceeding in Italy. Moby asserted claims against Morgan Stanley and another creditor for allegedly interfering with Moby’s business relations with a subset of creditors who supported Moby’s restructuring plan.
  • Represented Akorn in litigation in the Delaware Court of Chancery regarding Fresenius’ termination of the parties’ $4.3 billion merger agreement. Following expedited proceedings, the case culminated in a one‑week bench trial and subsequent expedited appeal. It is one of a handful of cases regarding termination rights arising from material adverse event (“MAE”) provisions in merger agreements to be tried to a decision, and the first such appeal decided by the Supreme Court of Delaware.
  • Represented Colgate-Palmolive in product liability lawsuits concerning the company’s talcum powder products. She represented the company in two jury trials in California state court, one of which resulted in a unanimous jury verdict in Colgate-Palmolive’s favor after a three-month jury trial, while the other settled on favorable terms. 

  • Represented Minerals Technologies’ (“MTI”) interests in the bankruptcy estate of Novinda Corporation. Cravath’s representation included defending MTI against allegations of fraud, breach of fiduciary duty and breach of contract in an arbitration brought by the estate.

Ms. Rosenberg also devotes significant time to pro bono work. She represents a proposed class of all current and future inmates at St. Clair Correctional Facility in Alabama who are exposed to shocking levels of violence and excessive use of force at the prison, in violation of the Eighth Amendment. Ms. Rosenberg also is a member of the Cravath team that brought a proposed class action against the Commissioners of the New York Board of Parole. Ms. Rosenberg previously represented African American and female plaintiffs in landmark pro bono litigation related to employment discrimination in Birmingham, Alabama—a matter the Firm had handled for decades.  In December 2020, the court granted the parties’ motion to terminate the consent decree with Jefferson County following years of negotiation and tangible strides by the County toward ensuring future hiring and promotion occur without discrimination.  Within Cravath, Ms. Rosenberg works to enhance the Firm’s D&I efforts, both through recruiting and as an active participant in Cravath’s Women’s Initiative.

Ms. Rosenberg has been recognized by The Legal 500 for her work in securities, financial services and general commercial litigation. She has also been included in Benchmark Litigation’s “40 & Under List.” Lawdragon has included her in its list of “500 Leading Litigators in America.” In 2022, Ms. Rosenberg was awarded Euromoney Legal Media Group’s Rising Star Award for “Best in Securities Litigation.”

Ms. Rosenberg was born in Miami, Florida. She received a B.A. summa cum laude from the University of Pennsylvania in 2008, where she was elected to Phi Beta Kappa, and a J.D. from Columbia Law School in 2011, where she was a Harlan Fiske Stone Scholar and the Managing Editor of the Journal of Transnational Law.

Ms. Rosenberg joined Cravath in 2011. In 2014, she served as a law clerk to Hon. Lewis A. Kaplan of the U.S. District Court for the Southern District of New York. Ms. Rosenberg rejoined Cravath in 2015 and was elected a partner in 2019.

Some of Ms. Rosenberg’s representative matters include:

Securities Litigation

  • Representing Micro Focus International (now OpenText) and certain individual defendants in putative securities class action litigation filed in New York federal court and in California state court alleging defendants made false and misleading statements and concealed material facts regarding Micro Focus’s $8.8 billion acquisition of certain of Hewlett Packard Enterprise’s software assets. 
  • Representing Anadarko Petroleum in class action securities litigation filed in Texas federal court and double derivative litigation filed in Delaware federal court alleging Anadarko made false and misleading statements concerning the company’s business and operations in the Shenandoah deepwater oil field.
  • Representing Dfinity, an international organization developing blockchain technology, in purported class action securities litigation filed in California state and federal court related to the issuance of Dfinity’s Internet Computer Project (“ICP”) master governance tokens.
  • Representing First Solar and certain of its senior executives in putative class action securities litigation filed in Arizona federal court alleging defendants made false and misleading statements regarding the company’s “Series 6” solar module and its project development business. Ms. Rosenberg obtained the dismissal of the action in January 2023, and continues to represent First Solar in related shareholder derivative litigation.
  • Won the dismissal of a shareholder derivative suit filed in New York state court against current and former directors and officers of Novartis and several Novartis subsidiaries alleging defendants breached their fiduciary duties to Novartis by failing to conduct adequate oversight of the company’s operations.
  • Represented Akorn and its executive officers in a consolidated securities class action lawsuit and a consolidated derivative action in Illinois federal court seeking damages for alleged misrepresentations related to the company’s acquisitions of Hi-Tech Pharmacal and VersaPharm.  She also represented Akorn in related shareholder derivative actions and an SEC investigation.
  • Represented First Solar in a securities class action and related opt‑out in Arizona federal court alleging that First Solar and several of its officers and executives concealed manufacturing issues with its solar modules. The class action settled on favorable terms on the eve of trial in January 2020.  
  • Represented Juno Therapeutics and certain of its executives in a securities class action suit in Washington federal court alleging that defendants failed to disclose side effects associated with an immunotherapy drug, resulting in a stock price drop when the clinical trial was halted. 
  • Represented Westpac Banking Corporation and its current chief executive officer in a putative class action securities litigation filed in Oregon federal court alleging that Westpac failed timely to disclose that it had failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre (“AUSTRAC”), contrary to Australian law.

Antitrust Litigation

  • Representing Morgan Stanley in individual and class action lawsuits in New York federal court alleging collusion among banks to restrain competition by preventing the development of anonymous exchange trading of various complex financial products, including credit default swaps, interest rate swaps and stock loans.
  • Represented Westpac Banking Corporation in a putative class action asserting, inter alia, antitrust, RICO and Commodity Exchange Act claims premised upon alleged manipulation of the Australian Bank Bill Swap Reference Rate (“BBSW”).
  • Represented Mylan Laboratories in consolidated antitrust litigation filed in Pennsylvania federal court regarding alleged reverse-payment settlement agreements concerning the narcolepsy drug modafinil.
  • Represented Sabre, a leading travel technology company, in its successful appeal to the Second Circuit of an adverse jury verdict in an antitrust lawsuit brought by US Airways concerning Sabre’s contract terms.
  • Represented Thai Airways in class action antitrust lawsuits filed in California and New York federal courts and in the Second Circuit alleging a price‑fixing conspiracy of passenger airfares among airlines.

  • Represented Time Inc. in an antitrust action brought by a wholesaler against magazine publishers and distributors alleging a group boycott and seeking over $1 billion in damages. The Southern District of New York granted summary judgment to defendants, and the decision was affirmed on appeal in the Second Circuit.

Other Commercial Litigation

  • Won the dismissal with prejudice of litigation filed against Morgan Stanley by Moby S.p.A., an Italian shipping company, in New York state court alleging tortious interference related to Moby’s restructuring proceeding in Italy. Moby asserted claims against Morgan Stanley and another creditor for allegedly interfering with Moby’s business relations with a subset of creditors who supported Moby’s restructuring plan.
  • Represented Akorn in litigation in the Delaware Court of Chancery regarding Fresenius’ termination of the parties’ $4.3 billion merger agreement. Following expedited proceedings, the case culminated in a one‑week bench trial and subsequent expedited appeal. It is one of a handful of cases regarding termination rights arising from material adverse event (“MAE”) provisions in merger agreements to be tried to a decision, and the first such appeal decided by the Supreme Court of Delaware.
  • Represented Colgate-Palmolive in product liability lawsuits concerning the company’s talcum powder products. She represented the company in two jury trials in California state court, one of which resulted in a unanimous jury verdict in Colgate-Palmolive’s favor after a three-month jury trial, while the other settled on favorable terms. 

  • Represented Minerals Technologies’ (“MTI”) interests in the bankruptcy estate of Novinda Corporation. Cravath’s representation included defending MTI against allegations of fraud, breach of fiduciary duty and breach of contract in an arbitration brought by the estate.

Ms. Rosenberg also devotes significant time to pro bono work. She represents a proposed class of all current and future inmates at St. Clair Correctional Facility in Alabama who are exposed to shocking levels of violence and excessive use of force at the prison, in violation of the Eighth Amendment. Ms. Rosenberg also is a member of the Cravath team that brought a proposed class action against the Commissioners of the New York Board of Parole. Ms. Rosenberg previously represented African American and female plaintiffs in landmark pro bono litigation related to employment discrimination in Birmingham, Alabama—a matter the Firm had handled for decades.  In December 2020, the court granted the parties’ motion to terminate the consent decree with Jefferson County following years of negotiation and tangible strides by the County toward ensuring future hiring and promotion occur without discrimination.  Within Cravath, Ms. Rosenberg works to enhance the Firm’s D&I efforts, both through recruiting and as an active participant in Cravath’s Women’s Initiative.

Ms. Rosenberg has been recognized by The Legal 500 for her work in securities, financial services and general commercial litigation. She has also been included in Benchmark Litigation’s “40 & Under List.” Lawdragon has included her in its list of “500 Leading Litigators in America.” In 2022, Ms. Rosenberg was awarded Euromoney Legal Media Group’s Rising Star Award for “Best in Securities Litigation.”

Ms. Rosenberg was born in Miami, Florida. She received a B.A. summa cum laude from the University of Pennsylvania in 2008, where she was elected to Phi Beta Kappa, and a J.D. from Columbia Law School in 2011, where she was a Harlan Fiske Stone Scholar and the Managing Editor of the Journal of Transnational Law.

Ms. Rosenberg joined Cravath in 2011. In 2014, she served as a law clerk to Hon. Lewis A. Kaplan of the U.S. District Court for the Southern District of New York. Ms. Rosenberg rejoined Cravath in 2015 and was elected a partner in 2019.

Education

  • J.D., 2011, Columbia Law School
    Harlan Fiske Stone Scholar
  • B.A., 2008, University of Pennsylvania
    Phi Beta Kappa, summa cum laude

Clerkships

  • Hon. Lewis A. Kaplan, U.S.D.C. for the Southern District of New York

Admitted In

  • New York

Rankings

Benchmark Litigation

  • 40 & Under List (2022)

Euromoney Legal Media Group

  • Americas Rising Star: Securities Litigation (2022)

Lawdragon

  • 500 Leading Litigators in America (2022)

The Legal 500 US

  • Financial Services Litigation (2021)
  • General Commercial (2020)
  • Securities Litigation (2022)

Deals & Cases

March 31, 2023

Morgan Stanley Wins Decision Affirming Dismissal of Antitrust Suit Against Major Banks

On Friday, March 24, a three‑judge panel for the U.S. Court of Appeals for the Second Circuit ruled in favor of Cravath client Morgan Stanley, banks Merrill Lynch, Credit Suisse, Goldman Sachs, J.P. Morgan and UBS, and EquiLend, a provider of electronic stock lending services.

Deals & Cases

September 01, 2022

Novartis Directors and Officers Win Dismissal of Shareholder Derivative Suit in New York Supreme Court

On August 19, 2022, the New York Supreme Court Commercial Division issued a decision dismissing a shareholder derivative action filed against current and former directors and officers of Novartis AG (“Novartis”) and several Novartis subsidiaries who, along with the Company, were represented by Cravath. Justice Margaret Chan of the Commercial Division dismissed the suit without prejudice to refile in Basel, Switzerland as required by a forum selection clause contained in Novartis’s Articles of Incorporation.

Deals & Cases

August 11, 2022

Morgan Stanley Wins Dismissal of Claims with Prejudice in Lawsuit Related to Italian Shipping Company’s Restructuring

On August 5, 2022, the New York Supreme Court, Commercial Division, dismissed with prejudice a lawsuit brought by Moby S.p.A., one of the world’s largest passenger shipping companies, against Cravath client Morgan Stanley and two of its employees. The lawsuit was related to Moby’s restructuring proceeding in Milan, Italy.

Deals & Cases

July 26, 2022

Dfinity Defendants Win Motion to Stay Pursuant to PSLRA in Purported Securities Class Action, Addressing Application in State Court

On July 25, 2022, Judge Danny Y. Chou of the Superior Court of the State of California, County of San Mateo, issued a decision holding that the automatic discovery stay pursuant to Section 77z‑1(b)(1) of the Private Securities Litigation Reform Act (the “PSLRA Stay”) applies not only in federal court, but also in state court. Judge Chou therefore granted Cravath clients Dfinity Foundation and Dfinity USA Research, LLC’s (together, the “Dfinity Defendants”) motion to stay discovery pending resolution of the Dfinity Defendants’ demurrer.

Deals & Cases

October 06, 2021

Morgan Stanley Wins Dismissal of Antitrust Suit

On October 1, 2021, the United States District Court for the Southern District of New York dismissed consolidated antitrust suits brought by the parent company of an electronic stock‑loan trading platform, SL‑x IP S.á.r.l., and its subsidiaries, against Cravath client Morgan Stanley, banks Merrill Lynch, Credit Suisse, Goldman Sachs, J.P. Morgan and UBS, and EquiLend, a provider of electronic stock lending services.

Accolades

October 10, 2022

Cravath Partners Honored with 2022 Americas Rising Stars Awards by Euromoney Legal Media Group

Six Cravath partners were honored as Rising Stars by Euromoney Legal Media Group in its 2022 Americas Awards, which were announced on October 6, 2022. Partners Sharonmoyee Goswami, C. Daniel Haaren, Lauren M. Rosenberg, Michael L. Arnold, Heather A. Benjamin and Matthew J. Bobby were recognized in the “Patent,” “Equity Capital Markets,” “Securities Litigation,” “Corporate Governance,” “Wealth Management” and “Labor & Employment” categories, respectively. The awards honor “the region’s emerging leaders,” who “have been rising to prominence within their chosen specialisms” and represent “the next generation of leaders in their fields.”

Accolades

July 27, 2022

Benchmark Litigation Names 10 Partners to its 2022 “40 & Under List”

Cravath partners Margaret T. Segall, Vanessa A. Lavely, Lauren R. Kennedy, Michael P. Addis, Justin C. Clarke, Sharonmoyee Goswami, Lauren M. Rosenberg, Helam Gebremariam, David H. Korn and Brittany L. Sukiennik were named by Benchmark Litigation to its 2022 “40 & Under List.” The list honors the achievements of the nation’s most accomplished litigators of 40 years old and under who have worked on high stakes and precedent setting cases. The list was compiled through a process involving peer and client review, along with examination of individual cases.

Activities & Publications

July 27, 2022

Lawdragon Highlights Cravath’s Pro Bono Efforts Over Four Decades in Jefferson County, Alabama

In its 2022 magazine, Lawdragon published an article entitled “The Long River of Justice: Cravath's Pro Bono Work In Alabama.” The feature highlights the Firm’s “remarkable” multi-decade efforts representing African-American and female plaintiffs who faced employment discrimination by governmental employers in Birmingham, Alabama. In the article, Associate Judge of the New York State Court of Appeals and former Cravath partner Rowan D. Wilson and Cravath partners Damaris Hernández and Lauren M. Rosenberg discuss the work they and others contributed to the landmark litigation, which over nearly four decades involved the close commitment of generations of Cravath partners, associates and support staff, beginning in 1983 with the late Robert D. Joffe, to the tune of more than 100,000 hours. The case contributed to the enactment of the Civil Rights Act of 1991, and concluded in December 2020 after the City of Birmingham succeeded in proving its diversification of the departments in question. “This has been the most rewarding work of my career,” Hernández told Lawdragon. “It just made me proud to be a Cravath partner.”

Lauren M. Rosenberg focuses her practice on a broad range of litigation, including general commercial, antitrust and securities matters. Ms. Rosenberg has represented a wide range of clients, including Akorn, Anadarko Petroleum, Colgate‑Palmolive, Dfinity, First Solar, Juno Therapeutics, Micro Focus International, Minerals Technologies, Morgan Stanley, Mylan, Novartis, Sabre, Time Inc. and Westpac Banking Corporation.

Some of Ms. Rosenberg’s representative matters include:

Securities Litigation

  • Representing Micro Focus International (now OpenText) and certain individual defendants in putative securities class action litigation filed in New York federal court and in California state court alleging defendants made false and misleading statements and concealed material facts regarding Micro Focus’s $8.8 billion acquisition of certain of Hewlett Packard Enterprise’s software assets. 
  • Representing Anadarko Petroleum in class action securities litigation filed in Texas federal court and double derivative litigation filed in Delaware federal court alleging Anadarko made false and misleading statements concerning the company’s business and operations in the Shenandoah deepwater oil field.
  • Representing Dfinity, an international organization developing blockchain technology, in purported class action securities litigation filed in California state and federal court related to the issuance of Dfinity’s Internet Computer Project (“ICP”) master governance tokens.
  • Representing First Solar and certain of its senior executives in putative class action securities litigation filed in Arizona federal court alleging defendants made false and misleading statements regarding the company’s “Series 6” solar module and its project development business. Ms. Rosenberg obtained the dismissal of the action in January 2023, and continues to represent First Solar in related shareholder derivative litigation.
  • Won the dismissal of a shareholder derivative suit filed in New York state court against current and former directors and officers of Novartis and several Novartis subsidiaries alleging defendants breached their fiduciary duties to Novartis by failing to conduct adequate oversight of the company’s operations.
  • Represented Akorn and its executive officers in a consolidated securities class action lawsuit and a consolidated derivative action in Illinois federal court seeking damages for alleged misrepresentations related to the company’s acquisitions of Hi-Tech Pharmacal and VersaPharm.  She also represented Akorn in related shareholder derivative actions and an SEC investigation.
  • Represented First Solar in a securities class action and related opt‑out in Arizona federal court alleging that First Solar and several of its officers and executives concealed manufacturing issues with its solar modules. The class action settled on favorable terms on the eve of trial in January 2020.  
  • Represented Juno Therapeutics and certain of its executives in a securities class action suit in Washington federal court alleging that defendants failed to disclose side effects associated with an immunotherapy drug, resulting in a stock price drop when the clinical trial was halted. 
  • Represented Westpac Banking Corporation and its current chief executive officer in a putative class action securities litigation filed in Oregon federal court alleging that Westpac failed timely to disclose that it had failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre (“AUSTRAC”), contrary to Australian law.

Antitrust Litigation

  • Representing Morgan Stanley in individual and class action lawsuits in New York federal court alleging collusion among banks to restrain competition by preventing the development of anonymous exchange trading of various complex financial products, including credit default swaps, interest rate swaps and stock loans.
  • Represented Westpac Banking Corporation in a putative class action asserting, inter alia, antitrust, RICO and Commodity Exchange Act claims premised upon alleged manipulation of the Australian Bank Bill Swap Reference Rate (“BBSW”).
  • Represented Mylan Laboratories in consolidated antitrust litigation filed in Pennsylvania federal court regarding alleged reverse-payment settlement agreements concerning the narcolepsy drug modafinil.
  • Represented Sabre, a leading travel technology company, in its successful appeal to the Second Circuit of an adverse jury verdict in an antitrust lawsuit brought by US Airways concerning Sabre’s contract terms.
  • Represented Thai Airways in class action antitrust lawsuits filed in California and New York federal courts and in the Second Circuit alleging a price‑fixing conspiracy of passenger airfares among airlines.

  • Represented Time Inc. in an antitrust action brought by a wholesaler against magazine publishers and distributors alleging a group boycott and seeking over $1 billion in damages. The Southern District of New York granted summary judgment to defendants, and the decision was affirmed on appeal in the Second Circuit.

Other Commercial Litigation

  • Won the dismissal with prejudice of litigation filed against Morgan Stanley by Moby S.p.A., an Italian shipping company, in New York state court alleging tortious interference related to Moby’s restructuring proceeding in Italy. Moby asserted claims against Morgan Stanley and another creditor for allegedly interfering with Moby’s business relations with a subset of creditors who supported Moby’s restructuring plan.
  • Represented Akorn in litigation in the Delaware Court of Chancery regarding Fresenius’ termination of the parties’ $4.3 billion merger agreement. Following expedited proceedings, the case culminated in a one‑week bench trial and subsequent expedited appeal. It is one of a handful of cases regarding termination rights arising from material adverse event (“MAE”) provisions in merger agreements to be tried to a decision, and the first such appeal decided by the Supreme Court of Delaware.
  • Represented Colgate-Palmolive in product liability lawsuits concerning the company’s talcum powder products. She represented the company in two jury trials in California state court, one of which resulted in a unanimous jury verdict in Colgate-Palmolive’s favor after a three-month jury trial, while the other settled on favorable terms. 

  • Represented Minerals Technologies’ (“MTI”) interests in the bankruptcy estate of Novinda Corporation. Cravath’s representation included defending MTI against allegations of fraud, breach of fiduciary duty and breach of contract in an arbitration brought by the estate.

Ms. Rosenberg also devotes significant time to pro bono work. She represents a proposed class of all current and future inmates at St. Clair Correctional Facility in Alabama who are exposed to shocking levels of violence and excessive use of force at the prison, in violation of the Eighth Amendment. Ms. Rosenberg also is a member of the Cravath team that brought a proposed class action against the Commissioners of the New York Board of Parole. Ms. Rosenberg previously represented African American and female plaintiffs in landmark pro bono litigation related to employment discrimination in Birmingham, Alabama—a matter the Firm had handled for decades.  In December 2020, the court granted the parties’ motion to terminate the consent decree with Jefferson County following years of negotiation and tangible strides by the County toward ensuring future hiring and promotion occur without discrimination.  Within Cravath, Ms. Rosenberg works to enhance the Firm’s D&I efforts, both through recruiting and as an active participant in Cravath’s Women’s Initiative.

Ms. Rosenberg has been recognized by The Legal 500 for her work in securities, financial services and general commercial litigation. She has also been included in Benchmark Litigation’s “40 & Under List.” Lawdragon has included her in its list of “500 Leading Litigators in America.” In 2022, Ms. Rosenberg was awarded Euromoney Legal Media Group’s Rising Star Award for “Best in Securities Litigation.”

Ms. Rosenberg was born in Miami, Florida. She received a B.A. summa cum laude from the University of Pennsylvania in 2008, where she was elected to Phi Beta Kappa, and a J.D. from Columbia Law School in 2011, where she was a Harlan Fiske Stone Scholar and the Managing Editor of the Journal of Transnational Law.

Ms. Rosenberg joined Cravath in 2011. In 2014, she served as a law clerk to Hon. Lewis A. Kaplan of the U.S. District Court for the Southern District of New York. Ms. Rosenberg rejoined Cravath in 2015 and was elected a partner in 2019.

Some of Ms. Rosenberg’s representative matters include:

Securities Litigation

  • Representing Micro Focus International (now OpenText) and certain individual defendants in putative securities class action litigation filed in New York federal court and in California state court alleging defendants made false and misleading statements and concealed material facts regarding Micro Focus’s $8.8 billion acquisition of certain of Hewlett Packard Enterprise’s software assets. 
  • Representing Anadarko Petroleum in class action securities litigation filed in Texas federal court and double derivative litigation filed in Delaware federal court alleging Anadarko made false and misleading statements concerning the company’s business and operations in the Shenandoah deepwater oil field.
  • Representing Dfinity, an international organization developing blockchain technology, in purported class action securities litigation filed in California state and federal court related to the issuance of Dfinity’s Internet Computer Project (“ICP”) master governance tokens.
  • Representing First Solar and certain of its senior executives in putative class action securities litigation filed in Arizona federal court alleging defendants made false and misleading statements regarding the company’s “Series 6” solar module and its project development business. Ms. Rosenberg obtained the dismissal of the action in January 2023, and continues to represent First Solar in related shareholder derivative litigation.
  • Won the dismissal of a shareholder derivative suit filed in New York state court against current and former directors and officers of Novartis and several Novartis subsidiaries alleging defendants breached their fiduciary duties to Novartis by failing to conduct adequate oversight of the company’s operations.
  • Represented Akorn and its executive officers in a consolidated securities class action lawsuit and a consolidated derivative action in Illinois federal court seeking damages for alleged misrepresentations related to the company’s acquisitions of Hi-Tech Pharmacal and VersaPharm.  She also represented Akorn in related shareholder derivative actions and an SEC investigation.
  • Represented First Solar in a securities class action and related opt‑out in Arizona federal court alleging that First Solar and several of its officers and executives concealed manufacturing issues with its solar modules. The class action settled on favorable terms on the eve of trial in January 2020.  
  • Represented Juno Therapeutics and certain of its executives in a securities class action suit in Washington federal court alleging that defendants failed to disclose side effects associated with an immunotherapy drug, resulting in a stock price drop when the clinical trial was halted. 
  • Represented Westpac Banking Corporation and its current chief executive officer in a putative class action securities litigation filed in Oregon federal court alleging that Westpac failed timely to disclose that it had failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre (“AUSTRAC”), contrary to Australian law.

Antitrust Litigation

  • Representing Morgan Stanley in individual and class action lawsuits in New York federal court alleging collusion among banks to restrain competition by preventing the development of anonymous exchange trading of various complex financial products, including credit default swaps, interest rate swaps and stock loans.
  • Represented Westpac Banking Corporation in a putative class action asserting, inter alia, antitrust, RICO and Commodity Exchange Act claims premised upon alleged manipulation of the Australian Bank Bill Swap Reference Rate (“BBSW”).
  • Represented Mylan Laboratories in consolidated antitrust litigation filed in Pennsylvania federal court regarding alleged reverse-payment settlement agreements concerning the narcolepsy drug modafinil.
  • Represented Sabre, a leading travel technology company, in its successful appeal to the Second Circuit of an adverse jury verdict in an antitrust lawsuit brought by US Airways concerning Sabre’s contract terms.
  • Represented Thai Airways in class action antitrust lawsuits filed in California and New York federal courts and in the Second Circuit alleging a price‑fixing conspiracy of passenger airfares among airlines.

  • Represented Time Inc. in an antitrust action brought by a wholesaler against magazine publishers and distributors alleging a group boycott and seeking over $1 billion in damages. The Southern District of New York granted summary judgment to defendants, and the decision was affirmed on appeal in the Second Circuit.

Other Commercial Litigation

  • Won the dismissal with prejudice of litigation filed against Morgan Stanley by Moby S.p.A., an Italian shipping company, in New York state court alleging tortious interference related to Moby’s restructuring proceeding in Italy. Moby asserted claims against Morgan Stanley and another creditor for allegedly interfering with Moby’s business relations with a subset of creditors who supported Moby’s restructuring plan.
  • Represented Akorn in litigation in the Delaware Court of Chancery regarding Fresenius’ termination of the parties’ $4.3 billion merger agreement. Following expedited proceedings, the case culminated in a one‑week bench trial and subsequent expedited appeal. It is one of a handful of cases regarding termination rights arising from material adverse event (“MAE”) provisions in merger agreements to be tried to a decision, and the first such appeal decided by the Supreme Court of Delaware.
  • Represented Colgate-Palmolive in product liability lawsuits concerning the company’s talcum powder products. She represented the company in two jury trials in California state court, one of which resulted in a unanimous jury verdict in Colgate-Palmolive’s favor after a three-month jury trial, while the other settled on favorable terms. 

  • Represented Minerals Technologies’ (“MTI”) interests in the bankruptcy estate of Novinda Corporation. Cravath’s representation included defending MTI against allegations of fraud, breach of fiduciary duty and breach of contract in an arbitration brought by the estate.

Ms. Rosenberg also devotes significant time to pro bono work. She represents a proposed class of all current and future inmates at St. Clair Correctional Facility in Alabama who are exposed to shocking levels of violence and excessive use of force at the prison, in violation of the Eighth Amendment. Ms. Rosenberg also is a member of the Cravath team that brought a proposed class action against the Commissioners of the New York Board of Parole. Ms. Rosenberg previously represented African American and female plaintiffs in landmark pro bono litigation related to employment discrimination in Birmingham, Alabama—a matter the Firm had handled for decades.  In December 2020, the court granted the parties’ motion to terminate the consent decree with Jefferson County following years of negotiation and tangible strides by the County toward ensuring future hiring and promotion occur without discrimination.  Within Cravath, Ms. Rosenberg works to enhance the Firm’s D&I efforts, both through recruiting and as an active participant in Cravath’s Women’s Initiative.

Ms. Rosenberg has been recognized by The Legal 500 for her work in securities, financial services and general commercial litigation. She has also been included in Benchmark Litigation’s “40 & Under List.” Lawdragon has included her in its list of “500 Leading Litigators in America.” In 2022, Ms. Rosenberg was awarded Euromoney Legal Media Group’s Rising Star Award for “Best in Securities Litigation.”

Ms. Rosenberg was born in Miami, Florida. She received a B.A. summa cum laude from the University of Pennsylvania in 2008, where she was elected to Phi Beta Kappa, and a J.D. from Columbia Law School in 2011, where she was a Harlan Fiske Stone Scholar and the Managing Editor of the Journal of Transnational Law.

Ms. Rosenberg joined Cravath in 2011. In 2014, she served as a law clerk to Hon. Lewis A. Kaplan of the U.S. District Court for the Southern District of New York. Ms. Rosenberg rejoined Cravath in 2015 and was elected a partner in 2019.

Education

  • J.D., 2011, Columbia Law School
    Harlan Fiske Stone Scholar
  • B.A., 2008, University of Pennsylvania
    Phi Beta Kappa, summa cum laude

Clerkships

  • Hon. Lewis A. Kaplan, U.S.D.C. for the Southern District of New York

Admitted In

  • New York

Rankings

Benchmark Litigation

  • 40 & Under List (2022)

Euromoney Legal Media Group

  • Americas Rising Star: Securities Litigation (2022)

Lawdragon

  • 500 Leading Litigators in America (2022)

The Legal 500 US

  • Financial Services Litigation (2021)
  • General Commercial (2020)
  • Securities Litigation (2022)

Deals & Cases

March 31, 2023

Morgan Stanley Wins Decision Affirming Dismissal of Antitrust Suit Against Major Banks

On Friday, March 24, a three‑judge panel for the U.S. Court of Appeals for the Second Circuit ruled in favor of Cravath client Morgan Stanley, banks Merrill Lynch, Credit Suisse, Goldman Sachs, J.P. Morgan and UBS, and EquiLend, a provider of electronic stock lending services.

Deals & Cases

September 01, 2022

Novartis Directors and Officers Win Dismissal of Shareholder Derivative Suit in New York Supreme Court

On August 19, 2022, the New York Supreme Court Commercial Division issued a decision dismissing a shareholder derivative action filed against current and former directors and officers of Novartis AG (“Novartis”) and several Novartis subsidiaries who, along with the Company, were represented by Cravath. Justice Margaret Chan of the Commercial Division dismissed the suit without prejudice to refile in Basel, Switzerland as required by a forum selection clause contained in Novartis’s Articles of Incorporation.

Deals & Cases

August 11, 2022

Morgan Stanley Wins Dismissal of Claims with Prejudice in Lawsuit Related to Italian Shipping Company’s Restructuring

On August 5, 2022, the New York Supreme Court, Commercial Division, dismissed with prejudice a lawsuit brought by Moby S.p.A., one of the world’s largest passenger shipping companies, against Cravath client Morgan Stanley and two of its employees. The lawsuit was related to Moby’s restructuring proceeding in Milan, Italy.

Deals & Cases

July 26, 2022

Dfinity Defendants Win Motion to Stay Pursuant to PSLRA in Purported Securities Class Action, Addressing Application in State Court

On July 25, 2022, Judge Danny Y. Chou of the Superior Court of the State of California, County of San Mateo, issued a decision holding that the automatic discovery stay pursuant to Section 77z‑1(b)(1) of the Private Securities Litigation Reform Act (the “PSLRA Stay”) applies not only in federal court, but also in state court. Judge Chou therefore granted Cravath clients Dfinity Foundation and Dfinity USA Research, LLC’s (together, the “Dfinity Defendants”) motion to stay discovery pending resolution of the Dfinity Defendants’ demurrer.

Deals & Cases

October 06, 2021

Morgan Stanley Wins Dismissal of Antitrust Suit

On October 1, 2021, the United States District Court for the Southern District of New York dismissed consolidated antitrust suits brought by the parent company of an electronic stock‑loan trading platform, SL‑x IP S.á.r.l., and its subsidiaries, against Cravath client Morgan Stanley, banks Merrill Lynch, Credit Suisse, Goldman Sachs, J.P. Morgan and UBS, and EquiLend, a provider of electronic stock lending services.

Accolades

October 10, 2022

Cravath Partners Honored with 2022 Americas Rising Stars Awards by Euromoney Legal Media Group

Six Cravath partners were honored as Rising Stars by Euromoney Legal Media Group in its 2022 Americas Awards, which were announced on October 6, 2022. Partners Sharonmoyee Goswami, C. Daniel Haaren, Lauren M. Rosenberg, Michael L. Arnold, Heather A. Benjamin and Matthew J. Bobby were recognized in the “Patent,” “Equity Capital Markets,” “Securities Litigation,” “Corporate Governance,” “Wealth Management” and “Labor & Employment” categories, respectively. The awards honor “the region’s emerging leaders,” who “have been rising to prominence within their chosen specialisms” and represent “the next generation of leaders in their fields.”

Accolades

July 27, 2022

Benchmark Litigation Names 10 Partners to its 2022 “40 & Under List”

Cravath partners Margaret T. Segall, Vanessa A. Lavely, Lauren R. Kennedy, Michael P. Addis, Justin C. Clarke, Sharonmoyee Goswami, Lauren M. Rosenberg, Helam Gebremariam, David H. Korn and Brittany L. Sukiennik were named by Benchmark Litigation to its 2022 “40 & Under List.” The list honors the achievements of the nation’s most accomplished litigators of 40 years old and under who have worked on high stakes and precedent setting cases. The list was compiled through a process involving peer and client review, along with examination of individual cases.

Activities & Publications

July 27, 2022

Lawdragon Highlights Cravath’s Pro Bono Efforts Over Four Decades in Jefferson County, Alabama

In its 2022 magazine, Lawdragon published an article entitled “The Long River of Justice: Cravath's Pro Bono Work In Alabama.” The feature highlights the Firm’s “remarkable” multi-decade efforts representing African-American and female plaintiffs who faced employment discrimination by governmental employers in Birmingham, Alabama. In the article, Associate Judge of the New York State Court of Appeals and former Cravath partner Rowan D. Wilson and Cravath partners Damaris Hernández and Lauren M. Rosenberg discuss the work they and others contributed to the landmark litigation, which over nearly four decades involved the close commitment of generations of Cravath partners, associates and support staff, beginning in 1983 with the late Robert D. Joffe, to the tune of more than 100,000 hours. The case contributed to the enactment of the Civil Rights Act of 1991, and concluded in December 2020 after the City of Birmingham succeeded in proving its diversification of the departments in question. “This has been the most rewarding work of my career,” Hernández told Lawdragon. “It just made me proud to be a Cravath partner.”

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • DISCLAIMERS
  • PRIVACY NOTICE
  • ALUMNI PORTAL
  • DIVERSITY & INCLUSION
  • OUR STORY

Attorney Advertising. © 2023   Cravath, Swaine & Moore LLP.